- EN
New EMCDDA products and services
Selected issue on injecting drug use
Trends in injecting drug use in Europe is the title of the latest EMCDDA Selected issue publication. This volume brings together data from a wide variety of sources as it describes Europe’s current drug injecting problem and plots its trends in recent years.
Responses to drug injecting and measures to reduce the harm caused by this form of drug use are also reviewed. The report finds that the available data point to a stable or declining trend of injecting in most European countries, with effective treatment and harm-reduction measures now reaching many users. Despite this, there is still a large population of drug injectors in Europe, and there continue to be signs of recent recruitment in some countries.
Available in English at www.emcdda.europa.eu/publications/selected-issues/injecting
Joint EMCDDA–Europol publication on cocaine
The EMCDDA and Europol committed in 2009 to a number of collaborative activities for the period 2009–12 (see Drugnet Europe No 66). Among these is an EMCDDA–Europol joint publication series covering key aspects of European drug markets.
Bringing together EMCDDA information and statistics on prevalence, health and drug research, with Europol data and knowledge on production, trafficking, markets and drugrelated crime, the publications offer an integrated analysis of the topics chosen. The second title in the series, to be released in March, is entitled: Cocaine: a European Union perspective in the global context. This follows the first volume, released last year, dedicated to methamphetamine.
Coming soon in English and Spanish at: www.emcdda.europa.eu/publications/joint-publications
Drug-related research on EMCDDA website
The EMCDDA website now hosts a dedicated thematic area on drug-related research. Here users may find information on: EU research funding programmes; lists of recent and ongoing research projects; related EMCDDA publications and online resources; and publications released at national level. Also provided are a ‘Latest news’ section and links to relevant scientific journals, newsletters and research institutions.
Available in English at www.emcdda.europa.eu/themes/research
EMCDDA scientist awarded
EMCDDA scientific writer, V. Anna Gyarmathy, PhD, MPH, has been awarded a one-year adjunct assistant professor position at the Johns Hopkins Bloomberg School of PublicHealth (Department of Health, Behaviour and Society). This honorary faculty position willhelp foster links between the EMCDDA and scientists outside the EU and will contribute toscientific excellence at the EMCDDA.
In this issue...
- 2010 priorities and budget
- Management Board: changes at the helm
- EMCDDA and Europol step up information collection on mephedrone
- Guidelines for collecting data on retail drug prices
- Hepatitis C prevalence as a possible indicator of injection-related HIV risk
- Health and prisons in Europe
- Best practice portal: upcoming developments
- European drug prevention quality standards
- Role of Community agencies in EU enlargement process reinforced
- EMCDDA signs accord with Ukrainian Ministry of Health
- New Czech penal code enters into force
- EMCDDA and Canadian partners outline areas for cooperation
- Implementation of the EMCDDA’s five key epidemiological indicators
- Reitox development strategy 2010–15
- Scientific Committee underlines importance of scientific publishing
Drugnet Europe is also available in downloadable PDF format, for printing or offline browsing.
Drugnet Europe is the EMCDDA's newsletter launched in September 1996. The newsletter provides regular and succint information on the Centre's projects and activities to a broad readership.
Page last updated: Friday, 12 March 2010